Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 5/2004

01-05-2004 | Original Article

Cancer-specific social support received by newly diagnosed cancer patients: validating the new Structural-Functional Social Support Scale (SFSS) measurement tool

Authors: Ulla-Sisko Lehto-Järnstedt, Markku Ojanen, Pirkko Kellokumpu-Lehtinen

Published in: Supportive Care in Cancer | Issue 5/2004

Login to get access

Abstract

Goals of work

To investigate potentially health-enhancing domains of cancer patients’ social relationships we evaluated various dimensions of social support as experienced in early cancer.

Patients and methods

In consecutive samples of 72 melanoma and 103 breast cancer patients diagnosed 3–4 months earlier, we evaluated the cancer-specific social network and received social support by the Structural-Functional Social Support Scale (SFSS) validated within the study. In addition, social support was measured by the MOS Social Support Survey as perceived support, and by Seeking Social Support items from the Ways of Coping Questionnaire as coping activity. SFSS measures the number of people who have been aware of the patient’s cancer and the amount of social support the patients have received from them.

Main results

A large number of people from various potential support-providing sources had been aware of the patients’ cancer, and the patients had received support through these interactions. A greater number of support providers did not mean an increase in the support received. Social support was distinguished into subgroups according to its source, but the division into functional support types was weak. Support assessed as perceived support or as a coping activity did not cover the received disease-specific support of several sources.

Conclusions

With the SFSS, it was possible to obtain detailed information on the disease-specific social network and social support. It may be beneficial to distinguish support according to the sources and to also measure support beyond the closest relationships. We hope that our measure and the results obtained will assist in identifying the targets for psychosocial interventions.
Literature
1.
Aalto A-M, Orhinmaa A, Aro A (1995) Social support and quality of life in Finnish general population. In: Rodriguez-Marin J (ed) Health psychology and quality of life research, vol 2. Murcia, Alicante, pp 620–626
2.
Blake-Mortimer J, Gore-Felton C, Kimerling R, Turner-Cobb JM, Spiegel D (1999) Improving the quality and quantity of life among patients with cancer: a review of the effectiveness of group psychotherapy. Eur J Cancer 35:1581–1586CrossRefPubMed
3.
Blanchard CG, Albrecht TL, Ruckdeschel JC, Grant CH, Hemmick RM (1995) The role of social support in adaptation to cancer and to survival. Journal of Psychosocial Oncology 13:75–95
4.
Bland JM, Altman DG (1997) Cronbach’s alpha [Statistics notes]. BMJ 314:572PubMed
5.
Bottomley A (1997) To randomise or not to randomise: methodological pitfalls of the RCT design in psychosocial intervention studies. Eur J Cancer Care 6:222–230CrossRef
6.
Broadhead WE, Kaplan BH (1991) Social support and the cancer patient. Cancer 67 [Suppl 3]:794–799
7.
Broadhead WE, Gehlbach SH, de Gruy FV, Kaplan BH (1988) The Duke-UNC Functional Social Support Questionnaire. Med Care 26:709–723PubMed
8.
Brown SD, Brady T, Lent RW, Wolfert J, Hall S (1987) Perceived social support among college students: Three studies of the psychometric characteristics and counseling uses of the social support inventory. J Counsel Psychol 34:337–354CrossRef
9.
Butow PN, Coates AS, Dunn SM (1999) Psychosocial predictors of survival in metastatic melanoma. J Clin Oncol 17:2256–2263PubMed
10.
Butow PN, Coates AS, Dunn SM (2000) Psychosocial predictors of survival: Metastatic breast cancer. Ann Oncol 11:469–474CrossRefPubMed
11.
Cassel J (1976) The contribution of the social environment to host resistance. Am J Epidemiol 104:107–123PubMed
12.
Cobb S (1976) Social support as a moderator of life stress. Psychosom Med 38:300–314PubMed
13.
Cohen S, Wills TA (1985) Stress, social support, and the buffering hypothesis. Psychol Bull 98:310–357CrossRefPubMed
14.
Dakof GA, Taylor SE (1990) Victims’ perceptions of social support: What is helpful from whom? J Pers Soc Psychol 58:80–89CrossRefPubMed
15.
Dolbeaut S, Szporn A, Holland JC (1999) Psycho-oncology: Where have we been? Where are we going? Eur J Cancer 35:1554–1558CrossRefPubMed
16.
Dunkel-Schetter C (1984) Social support and cancer: Findings based on patient interviews and their implications. J Soc Issues 40:77–98
17.
Dunkel-Schetter C, Bennett TL (1990) Differentiating the cognitive and behavioral aspects of social support. In: Sarason BR, Sarason IG, Pierce GR (eds) Social support: An interactional view. Wiley, New York, pp 267–296
18.
Dunkel-Schetter C, Folkman S, Lazarus RS (1987) Correlates of social support receipt. J Pers Soc Psychol 53:71–80CrossRefPubMed
19.
Eriksen W (1994) The role of social support in the pathogenesis of coronary hearth disease. A literature review. Family Practice 11:201–209PubMed
20.
Fawzy FI (1999) Psychosocial interventions for patients with cancer: What works and what doesn’t. Eur J Cancer 35:1559–1564CrossRefPubMed
21.
Fawzy FI, Fawzy NW, Arndt LA, Pasnau RO (1995) Critical review of psychosocial interventions in cancer care. Arch Gen Psychiatry 52:100–113PubMed
22.
Fife BL, Kennedy VN, Robinson L (1994) Gender and adjustment to cancer: Clinical implications. Journal of Psychosocial Oncology 12:1–20
23.
Flaherty J, Richman J (1989) Gender differences in the perception and utilization of social support: Theoretical perspectives and an empirical test. Soc Sci Med 28:1221–1228CrossRefPubMed
24.
Fobair P (1997a) Cancer support groups and group therapies: Part I. Historical and theoretical background and research on effectiveness. Journal of Psychosocial Oncology 15:63–81
25.
Fobair P (1997b) Cancer support groups and group therapies: Part II. Process, organizational, leadership, and patient issues. Journal of Psychosocial Oncology 15:123–147
26.
Folkman S, Lazarus RS (1988) Manual for the ways of coping questionnaire. Consulting Psychologists Press, Palo Alto
27.
Folkman S, Lazarus RS, Gruen RJ, DeLongis A (1986a) Appraisal, coping, health status, and psychological symptoms. J Pers Soc Psychol 50:571–579CrossRefPubMed
28.
Folkman S, Lazarus RS, Dunkel-Shetter C, DeLongis A, Gruen RJ (1986b) Dynamics of stressful encounter: cognitive appraisal, coping, and encounter outcomes. J Pers Soc Psychol 50:992–1003CrossRefPubMed
29.
Folkman S, Chesney M, McKusick L, Ironson G, Johnson DS, Coates TJ (1991) Translating coping theory into an intervention. In: Eckenrode J (ed) The social context of coping. Plenum, New York, pp 239–260
30.
Funch DP, Marshall JR, Gebhardt GP (1986) Assessment of a short scale to measure social support. Soc Sci Med 23:337–344CrossRefPubMed
31.
Gray RE, Goel V, Fitch MI, Franssen E, Labrecque M (2002) Supportive care provided by physicians and nurses to women with breast cancer. Results from a population-based survey. Support Care Cancer 10:647–652CrossRefPubMed
32.
Holahan CJ, Moos RH (1986) Personality, coping, and family resources in stress resistance: A longitudinal analysis. J Pers Soc Psychol 51:389–395CrossRefPubMed
33.
House JS, Robbins C, Metzner HL (1982) The association of special relationships and activities with mortality: Prospective evidence from the Tecumseh community health study. Am J Epidemiol 116:123–140PubMed
34.
House JS, Landis KR, Umberson D (1988) Social relationships and health. Science 241:540–545PubMed
35.
Iacovino V, Reesor K (1997) Literature on interventions to address cancer patients’ psychosocial needs: What does it tell us? Journal of Psychosocial Oncology 15:47–71
36.
Lazarus RS (1990) Stress, coping, and illness. In: Friedman HS (ed) Personality and disease. Wiley, New York, pp 97–120
37.
Lazarus RS (1993) Coping theory and research: past, present, and future. Psychosom Med 55:234–247PubMed
38.
Lehto-Järnstedt U-S (2000) Social Support and Psychological Stress Processes in the Early Phase of Cancer. Acta Universitatis Tamperensis 765. Vammalan kirjapaino Oy, Vammala. Also available at Acta Electronica Universitatis Tamperensis 53: http://​acta.​uta.​fi
39.
McDowell I, Newell C (1996) Social health. In: Measuring health. A guide to rating scales and questionnaires. Oxford University Press, Oxford, pp 122–176
40.
van der Molen B (1999) Relating information needs to the cancer experience: 1. Information as a key coping strategy. Eur J Cancer Care 8:238–244CrossRef
41.
Mossman J, Boudioni M, Slevin ML (1999) Cancer information: a cost-effective intervention. Eur J Cancer 35:1587–1591PubMed
42.
Orth-Gomer K, Unden A-L (1987) The measurement of social support in population surveys. Soc Sci Med 24:83–94CrossRefPubMed
43.
O’Reilly P (1988) Methodological issues in social support and social network research. Soc Sci Med 26:863–873CrossRefPubMed
44.
Ross L, Boesen EH, Dalton SO, Johansen C (2002) Mind and cancer: does psychosocial intervention improve survival and psychological well being? Eur J Cancer 38:1447–1457CrossRefPubMed
45.
Rowland JH (1989) Interpersonal resources: Social support. In: Holland JC, Rowland JH (eds) Handbook of psychooncology, psychological care of the patient with cancer. Oxford University Press, New York, pp 58–71
46.
Sarason IG, Levine HM, Basham RB, Sarason BR (1983) Assessing social support: The social support questionnaire. J Pers Soc Psychol 44:127–139CrossRef
47.
Sarason BR, Sarason IG, Pierce GR (1990) Traditional views of social support and their impact on assessment. In: Sarason BR, Sarason IG, Pierce GR (eds) Social support: An interactional view. Wiley, New York, pp 9–25
48.
49.
50.
Spiegel D, Bloom JR, Kraemer HC, Gottheil E (1989) Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet II:888–891CrossRef
51.
52.
Söllner W, Zschocke I, Zingg-Schir M, Stein B, Rumpold G, Fritsch P, Augustin M (1999) Interactive patterns of social support and individual coping strategies in melanoma patients and their correlations with adjustment to illness. Psychosomatics 40:239–250PubMed
53.
54.
Vaux A (1985) Variations of social support associated with gender, ethnicity, and age. J Soc Issues 41:89–110
55.
Winemiller DR, Mitchell ME, Sutliff J, Cline DJ (1993) Measurement strategies in social support: A descriptive review of the literature. J Clin Psychol 49:638–648PubMed
Metadata
Title
Cancer-specific social support received by newly diagnosed cancer patients: validating the new Structural-Functional Social Support Scale (SFSS) measurement tool
Authors
Ulla-Sisko Lehto-Järnstedt
Markku Ojanen
Pirkko Kellokumpu-Lehtinen
Publication date
01-05-2004
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 5/2004
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-004-0620-7

Other articles of this Issue 5/2004

Supportive Care in Cancer 5/2004 Go to the issue

Forthcoming Meetings

May 2004

Original Article

A qualitative study of head and neck cancer

Supportive Care International

Why Taiwanese hospice patients want to stay in hospital: health-care professionals’ beliefs and solutions

Short Communication

Sleep disorders in advanced cancer patients: prevalence and factors associated

Original Article

Postoperative education concerning the use of the upper limb, and exercise and treatment of the upper limb: cross-sectional survey of 105 breast cancer patients

Original Article

Assessment of peri-operative quality of life in patients undergoing surgery for gastrointestinal cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits